Verified email at
Cited by
Cited by
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy
R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ...
Cancer treatment reviews 63, 40-47, 2018
FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor–expressing metastatic colorectal cancer patients treated with single-agent†…
WU Zhang, M Gordon, AM Schultheis, DY Yang, F Nagashima, M Azuma, ...
Journal of clinical oncology 25 (24), 3712-3718, 2007
Primary tumor location as a prognostic factor in metastatic colorectal cancer
F Loupakis, D Yang, L Yau, S Feng, C Cremolini, W Zhang, MKH Maus, ...
Journal of the National Cancer Institute 107 (3), dju427, 2015
Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Y Ning, PC Manegold, YK Hong, W Zhang, A Pohl, G Lurje, T Winder, ...
International journal of cancer 128 (9), 2038-2049, 2011
A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
J Stoehlmacher, DJ Park, W Zhang, D Yang, S Groshen, S Zahedy, ...
British journal of cancer 91 (2), 344-354, 2004
Association Between Glutathione S-Transferase P1, T1, and M1 Genetic Polymorphism and Survival of Patients With Metastatic Colorectal Cancer
J Stoehlmacher, DJ Park, W Zhang, S Groshen, DD Tsao-Wei, MC Yu, ...
Journal of the National Cancer Institute 94 (12), 936-942, 2002
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels
MV Mandola, J Stoehlmacher, W Zhang, S Groshen, CY Mimi, S Iqbal, ...
Pharmacogenetics and Genomics 14 (5), 319-327, 2004
A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer
DJ Park, J Stoehlmacher, W Zhang, DD Tsao-Wei, S Groshen, HJ Lenz
Cancer research 61 (24), 8654-8658, 2001
Molecular determinants of cetuximab efficacy
D Vallböhmer, W Zhang, M Gordon, DY Yang, J Yun, OA Press, ...
Journal of Clinical Oncology 23 (15), 3536-3544, 2005
Gender disparities in metastatic colorectal cancer survival
A Hendifar, D Yang, F Lenz, G Lurje, A Pohl, C Lenz, Y Ning, W Zhang, ...
Clinical Cancer Research 15 (20), 6391-6397, 2009
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ...
The Journal of clinical investigation 128 (11), 4912-4923, 2018
Cancer dormancy: a model of early dissemination and late cancer recurrence
D PŠez, MJ Labonte, P Bohanes, W Zhang, L Benhanim, Y Ning, ...
Clinical Cancer Research 18 (3), 645-653, 2012
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab
AM Schultheis, G Lurje, KE Rhodes, W Zhang, D Yang, AA Garcia, ...
Clinical Cancer Research 14 (22), 7554-7563, 2008
Outlooks on Epstein-Barr virus associated gastric cancer
M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ...
Cancer treatment reviews 66, 15-22, 2018
ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.
DJ Park, W Zhang, J Stoehlmacher, D Tsao-Wei, S Groshen, J Gil, J Yun, ...
Clinical advances in hematology & oncology: H&O 1 (3), 162-166, 2003
A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with†…
W Zhang, T Winder, Y Ning, A Pohl, D Yang, M Kahn, G Lurje, MJ Labonte, ...
Annals of Oncology 22 (1), 104-109, 2011
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer
S Iqbal, B Goldman, CM Fenoglio-Preiser, HJ Lenz, W Zhang, ...
Annals of Oncology 22 (12), 2610-2615, 2011
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
G Lurje, W Zhang, AM Schultheis, D Yang, S Groshen, AE Hendifar, ...
Annals of Oncology 19 (10), 1734-1741, 2008
B cell and B cell-related pathways for novel cancer treatments
R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ...
Cancer treatment reviews 73, 10-19, 2019
Influence of sex on the survival of patients with esophageal cancer
P Bohanes, D Yang, RS Chhibar, MJ Labonte, T Winder, Y Ning, A Gerger, ...
Journal of Clinical Oncology 30 (18), 2265, 2012
The system can't perform the operation now. Try again later.
Articles 1–20